uniQure N.V. (QURE)
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.
Address
PAASHEUVELWEG 25A
AMSTERDAM, P7 1105 BP
Founded
2012
Number of Employees
480
Website
http://www.uniqure.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)